Polling data shows the size of One Nation’s victory in Farrer; The government is preparing to release the federal budget; Iran responds to latest US ceasefire proposal

Australian biotech giant CSL has surprised the stock market after announcing a write-down of more than $US5 billion and cutting its revenue outlook for 2026 to $US15.2 billion and net profit (excluding restructuring and impairment charges) to $US3.1 billion. Related…










